Business Description
SymBio Pharmaceuticals Ltd
ISIN : US87150Y1001
Share Class Description:
SYMQY: ADRTotal Employee Number:
94Description
SymBio Pharmaceuticals Ltd is a biopharmaceutical company engaged in development of new drugs with a primary focus on the treatment of rare diseases, mainly in the areas of oncology, hematology and multiple viral infections, and conduct integrated business activities that encompass search for new drug candidates, development, manufacturing, and sales.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.85 | |||||
Equity-to-Asset | 0.08 | |||||
Debt-to-Equity | 4.44 | |||||
Debt-to-EBITDA | -0.18 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | -15.17 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -53.1 | |||||
3-Year Book Growth Rate | -53.7 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
6-1 Month Momentum % | -12.42 | |||||
12-1 Month Momentum % | -53.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.11 | |||||
Quick Ratio | 1.04 | |||||
Cash Ratio | 0.73 | |||||
Days Inventory | 271.1 | |||||
Days Sales Outstanding | 60.88 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -14.6 | |||||
Shareholder Yield % | -22.43 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 71.86 | |||||
Operating Margin % | -439.49 | |||||
Net Margin % | -458.55 | |||||
EBITDA Margin % | -452.57 | |||||
FCF Margin % | -352.69 | |||||
OCF Margin % | -346.44 | |||||
ROE % | -328.32 | |||||
ROA % | -144.95 | |||||
ROIC % | -781.18 | |||||
3-Year ROIIC % | 309.06 | |||||
ROC (Joel Greenblatt) % | -1423.83 | |||||
ROCE % | -196.82 | |||||
Years of Profitability over Past 10-Year | 2 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 3.27 | |||||
PB Ratio | 23.98 | |||||
Price-to-Tangible-Book | 27.9 | |||||
EV-to-EBIT | -0.81 | |||||
EV-to-EBITDA | -0.81 | |||||
EV-to-Forward-EBITDA | 10.83 | |||||
EV-to-Revenue | 3.67 | |||||
EV-to-Forward-Revenue | 1.95 | |||||
EV-to-FCF | -1.01 | |||||
Price-to-GF-Value | 1.27 | |||||
Price-to-Median-PS-Value | 0.9 | |||||
| Price-to-Net-Current-Asset-Value | 27.9 | |||||
Earnings Yield (Greenblatt) % | -123.46 | |||||
FCF Yield % | -83.85 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:SYMQY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SymBio Pharmaceuticals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 8.471 | ||
| EPS (TTM) ($) | -0.68 | ||
| Beta | -0.3046 | ||
| 3-Year Sharpe Ratio | -1.14 | ||
| 3-Year Sortino Ratio | -1.21 | ||
| Volatility % | 49.35 | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | 0.000007 | ||
| 20-Day SMA ($) | 0.5579 | ||
| 12-1 Month Momentum % | -53.29 | ||
| 52-Week Range ($) | 0.5579 - 1.1944 | ||
| Shares Outstanding (Mil) | 72.15 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
SymBio Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
SymBio Pharmaceuticals Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
SymBio Pharmaceuticals Ltd Frequently Asked Questions
What is SymBio Pharmaceuticals Ltd(SYMQY)'s stock price today?
The current price of SYMQY is $0.56. The 52 week high of SYMQY is $1.19 and 52 week low is $0.56.
When is next earnings date of SymBio Pharmaceuticals Ltd(SYMQY)?
The next earnings date of SymBio Pharmaceuticals Ltd(SYMQY) is .
Does SymBio Pharmaceuticals Ltd(SYMQY) pay dividends? If so, how much?
SymBio Pharmaceuticals Ltd(SYMQY) does not pay dividend.
Guru Commentaries on OTCPK:SYMQY
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on SymBio Pharmaceuticals Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers